Chartwell Investment Partners, LLC Bio N Tech Se Transaction History

Chartwell Investment Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 14, 2023	BUY	$122.57 - $153.67 $980 - $1,229	8 Added 0.18%	4,437 $553,000
Q4 2022 Feb 15, 2023	SELL	$118.43 - $186.05 $1,184 - $1,860	-10 Reduced 0.23%	4,429 $665,000
Q3 2022 Oct 27, 2022	SELL	$127.65 - $183.11 $4,850 - $6,958	-38 Reduced 0.85%	4,439 $599,000
Q1 2022 Apr 26, 2022	SELL	$126.25 - $231.85 $126 - $231	-1 Reduced 0.02%	4,477 $763,000
Q4 2021 Feb 15, 2022	SELL	$216.64 - $362.52 $3,032 - $5,075	-14 Reduced 0.31%	4,478 $1.15 Million
Q3 2021 Nov 16, 2021	BUY	$205.93 - $447.23 $925,037 - $2.01 Million	4,492 New	4,492 $1.23 Million

360

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $30B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Chartwell Investment Partners, LLC with notifications on news.